Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido

Abstract

loading...

About

This paper, published in 1950, received 410 indexed citations. Written by Vinod P. Balachandran, Michael J. Cavnar, Shan Zeng, Zubin M. Bamboat, Lee M. Ocuin, Eric C. Sorenson, Rachel Popow, Charlotte E. Ariyan, Ferdinand Rossi and Peter Besmer covering the research area of Gastroenterology, Immunology and Oncology. It is primarily cited by scholars working on Immunology (209 citations), Oncology (200 citations) and Gastroenterology (100 citations). Published in Nature Medicine.

In The Last Decade

doi.org/10.1038/nm.2438 →

Countries where authors are citing Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido

Since Specialization
Citations

This map shows the geographic impact of Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido more than expected).

Fields of papers citing Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1038/nm.2438.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026